Работы, цитирующие эту работу

Работ: 2

Работа: ABI:AkademIndex/openalex/2026.other.947909

1. Leveraging Chimeric Antigen Receptor-T Cell Therapy for the Treatment of Multiple Sclerosis: Bridging Oncology and Neurology

   Matlyuba Sanoyeva, Наргиза Насирдинова, M. Gulova +5

   Статья2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.039242

2. Impact of age, BMI, and renal function adjustment on interpretation of serum NfL and GFAP in multiple sclerosis progression: a scoping review

   Aziza Shavkatovna Kadirova, Gulnora Kutpitdinovna Rakhmatullaeva, Javlon Salimjonov

   Статья2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.054968